Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

423 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 423 results

Not applicableStudy completedNCT01619007
What this trial is testing

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Who this might be right for
Deep Vein ThrombosisVenous Thrombosis
Bayer 5,145
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Not applicableLooking for participantsNCT06556446
What this trial is testing

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 2,800
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Testing effectiveness (Phase 2)Study completedNCT02271399
What this trial is testing

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Hanyang University Seoul Hospital 156
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Not applicableStudy completedNCT05546957
What this trial is testing

Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

Who this might be right for
Healthy Volunteer
Regeneron Pharmaceuticals 60
Very early researchUnknownNCT05308030
What this trial is testing

Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization

Who this might be right for
Peripheral Arterial Disease
Assiut University 100
Large-scale testing (Phase 3)Ended earlyNCT04508023
What this trial is testing

Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Janssen Research & Development, LLC 1,284
Not applicableUnknownNCT04419012
What this trial is testing

Polish Atrial Fibrillation (POL-AF) Registry

Who this might be right for
Atrial Fibrillation
Jan Kochanowski University 4,000
Testing effectiveness (Phase 2)Study completedNCT00973323
What this trial is testing

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Who this might be right for
Atrial Fibrillation
Bayer 100
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableStudy completedNCT01710267
What this trial is testing

Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)

Who this might be right for
Healthy
Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD 20
Large-scale testing (Phase 3)Looking for participantsNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University 200
Not applicableStudy completedNCT05319340
What this trial is testing

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Who this might be right for
Anticoagulants
I.M. Sechenov First Moscow State Medical University 1,000
Large-scale testing (Phase 3)Study completedNCT05705089
What this trial is testing

Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI

Who this might be right for
Left Ventricular ThrombusST Segment Elevation Myocardial Infarction
Rajaie Cardiovascular Medical and Research Center 50
Early research (Phase 1)Ended earlyNCT02058199
What this trial is testing

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery

Who this might be right for
Gastric Bypass Status
State University of New York - Upstate Medical University 2
Load More Results